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Sarcoid tumors were described by means of  histopathological and molecular procedures 
in a 5-year-old donkey.  Histopathological examination showed epithelial changes 
including hyperkeratosis, epithelial hyperplasia, koilocytosis, and rete peg formation. 
Neoplastic fi broblastic cells were plumb, large spindle to stellate and embedded in dense 
collagenous tissue. Results of  Polymerase Chain Reaction and DNA sequence analysis 
showed that the etiological agent belonged to Bovine Papilloma Virus-II species in the 
delta papilloma virus genus. This case study represents the fi rst report demonstrating 
the presence of  Bovine Papilloma Virus-II in donkey sarcoid.
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INTRODUCTION
Papillomaviridae are non-e ncapsulated oncogenic viruses with circular, double-stranded 
DNA, infecting the epithelium. Most of  the papillomaviruses are highly host specifi c, 
however, bovine papilloma virus (BPV) has cosmopolitan features infecting both 
bovine and equine species [1]. These viruses are classifi ed in 5 genera including 
Deltapapillomavirus, Xipapillomavirus, Epsilonpapillomavirus, Dyoxipapillomavirus and 
Dyokappapapillomavirus. Other new BPVs (18, 19 and 21) are not included in any genus 
[2]. The classifi cation is based on genomic DNA homology, particularly the highly 
conserved L1 gene encoding a structural protein [3]. 
BPV-1, 2 and 13 are responsible for the occurrence of  sarcoid tumors in equids [4]. 
These tumors are locally aggressive, fi broblastic benign proliferations, which are the 
most common skin tumors in horses. They are often present at sites of  previous 
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trauma or scarring with typical clinical appearance. However, the diagnosis is based on 
histopathological and molecular analysis. Their prevalence ranges from 1% to 12% in 
horses [4,5]. Most of  the studies on sarcoid tumors are focused on horses, however 
limited numbers of  studies are available in other equids [5]. Despite some studies 
in equine sarcoid and bovine papilloma virus exist in Turkey [6,7], to the authors’ 
knowledge, no report on sarcoid in donkeys is available. 
The aim of  this report is to describe the clinical, pathological and molecular fi ndings 
of  equine sarcoma on the skin of  the lower eyelid in a 5-year-old donkey.
CASE REPORT
A fi ve-year-old donkey was referred to the Hospital of  Veterinary Medical School 
of  Firat University. Grossly, the right lower eyelid was thickened by the mass (Fig-
1A) which was surgically resected. The tumor also caused keratitis characterized by 
vascularization, edema and scar formation. Topical ophthalmic pomade (Polymixine B 
Sulfate, Oxytetracycline Hcl and Terramycin) was used for keratitis. The cut surfaces 
of  the tumor had a lobular appearance and hard in consistency.  The dimension was 
Figure 1. a. Well circumsized mass having granular surface on the lower eyelid; b. Rete ridge 
formation (arrow), koilocytosis (arrow heads) and perpendicularly oriented fi broblasts (star) 
at  the dermal-epidermal connection; c. Diffuse and strong immune reaction characterized by 
granular cytoplasmic staining to vimentin in the dermis; d. Diffuse and strong immunoreaction 
characterized by cytoplasmic staining to S-100 in the dermis; e. 2% Agarose gel electrophoresis 
of  PCR products amplifi ed with semi-nested PCR from the clinical sample taken in eyelid. M; 
100 bp DNA ladder (Sigma, USA).
Lane 1: negative control (dH2O), Lane 2:  semi-nested PCR of  the clinical sample; 386 bp.
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4x5x3 cm and weighed 140 grams. Recurrence occurred 6 months after surgery and 
euthanasia was performed upon the owner’s request.
Tissue samples were fi xed in 10% formalin solution. Paraffi n blocks prepared by routine 
methods were cut approximately 5 μm in thickness and stained with hematoxylin-
eosin method (H&E).
Immunohistochemistry analysis for vimentin and S-100 was performed using 
autostainer (Ventana Benchmark Ultra), whereas immunohistochemistry for BPV was 
manually performed. Details of  primary antibodies used for immunohistochemical 
analysis are given in Table-1. During all staining steps, the sections were washed in 
PBS (Phosphate Buffered Saline, pH 7.6). For immunolabeling 3,3’, diaminobenzidine 
(DAB) and Mayer’s hematoxylin were used as the chromogen and the counterstain, 
respectively.




































Serial sections in 4 µm thickness were deparaffi nized in xylene and rehydrated through 
graded alcohol. The sections were placed in citrate buffer saline (pH 6.0) in a microwave 
oven for 20 min for antigen retrieval. Endogenous peroxidase activity was blocked with 
5.0% H2O2 in methanol for 10 min. Primary antibodies were omitted from negative 
control sections, whereas, for the positive control, bovine viral papilloma samples were 
used from the archive. 
Genomic DNA was extracted from the mass using a commercial extraction kit (Wizard 
Genomic DNA Extraction System) as recommended by the manufacturer (Promega 
Corp., Madison, WI). The DNA pellets were dissolved in 50 µl distilled water and were 
stored at -20 ºC pending analysis. 
Semi-nested PCR method for BPV-2 was used as previously described [8]. PCR 
reaction was carried out in a total of  50 µl PCR mixture including 5µl of  template 
DNA, 5 µl 10 x PCR Buffer (670mM Tris-HCl, pH 8,8, 0.1% Tween-20, 160mM 
(NH4)2SO4, 25mM Magnesium chloride), 2mM from each of  the 4 deoxynucleotides, 
1U Taq DNA polymerase (Bioron), 0.2 M primers [BPVP1 (5´- TGT TCC CAA AGT 
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TGC TG-3´) and  BPVP2 (5´- CAT TTT GAG GTA GTC TGG-3´)]. Amplifi cations 
were carried out in two rounds. First stage PCR was performed with the following 
cycling profi le: an initial step of  2 min at 95 ºC, followed by 40 cycles of  1 min/94 ºC, 
1 min/55 ºC, 1 min/72 ºC, and a fi nal extension step of  5 min/ 72 ºC. The second 
stage PCR was carried out with BPVP-1 and BPVP-3 (5´- ATT CTA AAG GAG GAC 
ACG -3) primers and 1 µl PCR product taken from the fi rst stage PCR under the same 
conditions. 
Genomic DNA was also used in the PCR step for diagnosis of  BPV-1 [9] and BPV-
13 [10]. PCR products were analyzed by electrophoresis in 2.0% agarose gel stained 
with ethidium bromide (0.5 µg/ml) and visualized under UV light. Sequence analysis 
of  amplifi cation detected at the expected size after electrophoresis was performed 
at Macrogen laboratory. The obtained sequence data were verifi ed by testing with 
BLASTN (http://www.ncbi.nlm.nih.gov) and stored in the GenBank database: 
MW053068 (strain name: EquineSarcoids/Asinus/TUR-2018).
The mass was well-circumscribed, not encapsulated and consisted of  a variable 
infi ltrative proliferation of  fi broblastic cells which were plumb, large spindle to 
stellate. The nuclei had granular chromatin with prominent nucleoli. Neoplastic 
cells embedded in dense collagenous tissue. Epithelial changes were hyperkeratosis, 
epithelial hyperplasia, koilocytosis, and rete peg formation (Fig-C). At the dermal-
epidermal conjunction, there were fi broblasts oriented perpendicularly to the 
basement membrane in the so-called “picket fence” arrangement (Fig-c). The number 
of  mitoses was low (1 in high-dry power fi eld).  
All the sections of  the tumor showed negative immunoreaction to BPV antibodies. 
However, in the positive control samples (bovine papilloma samples), strong and 
diffuse nuclear immunoractivity was present in the stratum granulosum and stratum 
corneum.  
As a result of  the semi-nested PCR performed with BPVP1- BPVP-3 primers a 
386 base pair (bp) specifi c band was detected in 2% agarose gel (Fig d). The PCR 
analysis performed with BPV-I and BPV-XIII specifi c primers did not result in any 
amplifi cation. BlastN analysis showed that the EquineSarcoids/Asinus/TUR-2018 
strain partial L1 gene shares 98.94% nucleotide (nt) identity with the TR-B27-BPV2 
L1 strain (KY781814.1; coverage of  100%) from Turkey and Aks-01 strain from China 
(KM455051.1; coverage of  100%) and 98.67% nt identity with BPV2_BR/02AC12 
strain  from Brazil (MH187961.1; coverage of  100%). These results showed that the 
papillomavirus strain obtained from the donkey is in the deltapapillomavirus genus 
and is highly identical with Bovine Papillomavirus-2 species.
BPV-1, BPV-2 and BPV-13 are the etiologic agents of  equine sarcoid tumors. Infection 
of  equids by a bovine virus is a rare example of  interspecies transmission for the 
papilloma virus. Delta-PVs transform mesenchymal cells to tumor cells via BPV 
E5 oncoprotein by binding and activating platelet-derived growth factor b receptor 
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(PDGF b-r) and increased expression of  the phosphoinositide 3-kinase-AKT-cyclin 
D3 pathway and c-Jun N-terminal kinase [11,12].
It might be challenging to differentiate the equine sarcoid from  soft tissue sarcomas 
especially if  the epidermal  component  had  been  lost  through ulceration, [7]. 
However, S100 is helpful and is expressed in sarcoids [13], but rarely expressed in 
equine soft tissue sarcomas. 
In a previous study, BPV-1 was reported in a donkey sarcoid [14]. In other surveys 
[15,16], BPV was reported in donkeys without strain information.
In conclusion; this is the fi rst report of  the equine sarcoid caused by BPV-2 in a 
donkey. Positive immunoreactivity to BPV could not be detected, most probably due 
to the abortive nature of  the infection.
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SARKOID DONJEG OČNOG KAPKA KOD MAGARCA (EQUUS 
ASINUS) IZAZVAN BOVINIM PAPILOMA 2 VIRUSOM   
EROKSUZ Yesari, ABAYLI Hasan, CANPOLAT Ibrahim, AKDENIZ INCILI 
Canan, KARABULUT Burak, TANRISEVER Murat,  BEYTUT Enver
Sarkoidi su opisani primenom histopatoloških i molelularanih metoda i procedura kod 
magarca, starog pet godina. Histopatološko ispitivanje, ukazalo je na promene u epitelu koje 
su uključivale hiperkeratozu, hiperplaziju epitela, koilocitozu i formiranje  invaginacija epitela 
ptema dubokom dermisu - rete peg. Fibroblastine neoplastične ćelije su bile krupne, ovalno-
vretenaste i zvezdaste, uronjene u tkivo bogato kolagenom. Ispitivanje PCR metodom kao 
i rezultati DNK sekvencioniranja pokazali su da je etiološki agens spadao u grupu bovinog 
papilomavirusa-2 koji pripada rodu delta papilomavirusa. Ova studija predstavlja prvi opisani 
slučaj prisustva papiloma virusa goveda-2 kod sarkoida magarca.
